search
Back to results

Negative Pressure Wound Therapy as a Drug Delivery System

Primary Purpose

Diabetic Foot Ulcers

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Cardinal Pro +Simultaneous Irrigation (NPWTi)
Cardinal Pro (NPWT) Therapy
Sponsored by
University of Texas Southwestern Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetic Foot Ulcers

Eligibility Criteria

21 Years - 89 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Diagnosis of diabetes mellitus Men/women ≥21 years old Foot or ankle wounds sized 5 cm2 -100 cm2 ABI≥0.5 or toe pressures >30 mmHg

Exclusion Criteria:

Active Charcot arthropathy Unable to use NPWT at home Untreated bone or soft tissue infection Unable to keep research appointments Active alcohol or substance abuse

Sites / Locations

  • UT Southwestern Medical Center at Dallas

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Cardinal Pro + Irrigation (NPWTi)

Cardinal Pro (NPWT) Therapy

Arm Description

Negative Pressure Wound Therapy with Irrigation: Quantum™ +Simultaneous Irrigation (NPWTi) - Negative Pressure Wound Therapy with Prontosan® Intervention is receiving the Cardinal Vac with Irrigation

Negative Pressure Wound Therapy without Irrigation: Quantum™ (NPWT) -Negative Pressure Wound Therapy (without Prontosan®) Intervention is receiving the Cardinal Vac without Irrigation

Outcomes

Primary Outcome Measures

Number of Participants Who Achieved Complete Healing or Coverage of the Study Wound
How many wounds fully healed in 16 weeks. Healing defined as fully epithelialized skin with no drainage.

Secondary Outcome Measures

Total Adverse Events of Participants
Total number of adverse events, including new foot ulcer formation, all-cause hospital readmission, and foot-related hospital readmission.
Number of Participants With Wound Dehiscence After Hospital Discharge
Dehiscence is defined as any part of a surgically closed wound that failed to heal when sutures were removed.

Full Information

First Posted
April 16, 2015
Last Updated
July 20, 2023
Sponsor
University of Texas Southwestern Medical Center
Collaborators
Parkland Health and Hospital System
search

1. Study Identification

Unique Protocol Identification Number
NCT02463487
Brief Title
Negative Pressure Wound Therapy as a Drug Delivery System
Official Title
Negative Pressure Wound Therapy as a Drug Delivery System
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
June 2, 2015 (Actual)
Primary Completion Date
December 28, 2019 (Actual)
Study Completion Date
August 1, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Texas Southwestern Medical Center
Collaborators
Parkland Health and Hospital System

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The investigators plan a randomized clinical trial of 150 patients with infected diabetes-related lower extremity wounds to compare the clinical and economic effectiveness of negative pressure wound therapy with continuous irrigation and negative pressure wound therapy without irrigation.
Detailed Description
The investigators will enroll 150 patients from two centers: The University of Texas Southwestern University Hospital and Parkland Hospital. The investigators will screen and enroll patients with wounds in the inpatient setting. Patients will be randomized to receive traditional NPWT or NPWT with continuous irrigation while they are hospitalized. The average hospitalization for patients that receive NPWT is 13.3 days. Patients that do not have their wound surgically closed during hospitalization will be discharged with negative pressure wound therapy for up to a total of four weeks of therapy. After discharge from the hospital, subjects will be seen twice weekly by home health, and will be evaluated in clinic every 7 days (±7 days) up to a total of 16-week period or until 30 days after the wound heals. Study Procedures: Screening Procedures Review and sign the Informed Consent and HIPAA Authorization The study doctor will review the inclusion and exclusion criteria Demographics (such as age, gender, race or ethnicity) Physical exam Sitting blood pressure and pulse Height and weight Collection of the medical and surgical history Collection of the history of the wound Wound assessment(s)/Debridement - various tests and measurements to assess the sensation (feeling) and circulation (blood flow) in the subject's feet and lower legs. None of these tests are invasive (using needles), uncomfortable or have risks greater than standard care. Wound imaging - photographs and images of the subject's wound using acetate tracings, a digital camera and an ARANZ camera (a special type of camera that uses computer software to calculate the volume of the wound) Hyperspectral imaging Vascular/Neurological evaluation Results of standard-of-care laboratory tests including a white blood cell count, blood chemistry (tests to see how well organs, such as the liver and kidneys are working), and blood glucose. Results of a serum pregnancy test (standard care for women of child-bearing potential as part of pre-op labs) will also be collected. About 2 tablespoons of blood will be drawn for these tests. Collection of a list of the subject's current medications, including prescriptions, over-the-counter medications, supplements and herbals. This visit will last about 2 hours. If the subject qualifies for the study, they will participate in the following procedures: Group Assignment If the researchers believe the subject can take part in this study, s/he will be assigned randomly (like a flip of a coin) to receive one of the following therapies: Negative Pressure Wound Therapy with Irrigation Negative Pressure Wound Therapy without Irrigation The group is assigned randomly (like flipping a coin). The sponsor or researchers do not know in advance what group assignment each subject will receive. Neither the subject nor the researchers will be allowed to choose which group s/he is assigned to. Study Intervention The subject will receive either: Cardinal Pro +Simultaneous Irrigation (NPWTi) - Negative Pressure Wound Therapy with Prontosan®, or Cardinal Pro (NPWT) Therapy (without Prontosan®) Assigned therapy will continue in the hospital until the physician determines that the wound is ready for closure. If the subject's wound is healing, study therapy will be discontinued and standard dressings will be applied. If surgical closure is needed, the subject will return to the Operating Room for a procedure to close the wound. If the wound is not ready for closure during the hospital stay, subjects will continue NPWT at home for the remainder of the 4 weeks of treatment. NPWT at home will be without irrigation (KCI VAC Via®). Procedures and Evaluations during the Research The study therapy will only be given while the subject is in the hospital. S/he will continue the therapy for up to 4 weeks or until the wound is closed. Once the therapy is stopped s/he will continue to be followed by the study doctor. After the subject is released from the hospital s/he will need to see the study doctor Every 7 days (±7 days). If the subject's wound does not heal before 56 days after his/her first surgery then s/he will no longer be taking part in the study. The study doctor will continue to check the wound. If the wound closes, s/he will see the study doctor 30 days later to have the closed wound checked. 12 Month Extension: After the end of the defined study period, the patients will be followed observationally by their electronic medical records for 12 months as it would not be feasible to ask them to return for an in-person evaluation as: patients have moved, no longer have correct contact information, as well as it would create a financial hardship on the patients to return for further visits. In order to more appropriately determine long term results from participation, a longer period of time of follow up is necessary. Related outcomes that we would like to follow over a 12-month duration are incidence of new foot ulcerations, re-ulceration of a previously healed foot wound, healing and time to healing of patients who took longer than the current study allows, duration of antibiotics received for foot infections, re-admissions to the hospital, need for subsequent surgery, amputation, loss of limb, and death. This expanded follow up period would provide valuable information to the long-term outcomes and complications of this high risk population and will help direct how future efforts may be better focused to reduce complications and improve outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetic Foot Ulcers

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
150 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Cardinal Pro + Irrigation (NPWTi)
Arm Type
Active Comparator
Arm Description
Negative Pressure Wound Therapy with Irrigation: Quantum™ +Simultaneous Irrigation (NPWTi) - Negative Pressure Wound Therapy with Prontosan® Intervention is receiving the Cardinal Vac with Irrigation
Arm Title
Cardinal Pro (NPWT) Therapy
Arm Type
Active Comparator
Arm Description
Negative Pressure Wound Therapy without Irrigation: Quantum™ (NPWT) -Negative Pressure Wound Therapy (without Prontosan®) Intervention is receiving the Cardinal Vac without Irrigation
Intervention Type
Device
Intervention Name(s)
Cardinal Pro +Simultaneous Irrigation (NPWTi)
Other Intervention Name(s)
• Negative Pressure Wound Therapy with Irrigation
Intervention Description
NPWT with low volume irrigation (15 cc/hr) with 1% polyhexanide biguanide (PHMB), Prontosan®
Intervention Type
Device
Intervention Name(s)
Cardinal Pro (NPWT) Therapy
Other Intervention Name(s)
• Negative Pressure Wound Therapy without Irrigation
Intervention Description
NPWT 125 mm Hg continuous pressure with foam interface
Primary Outcome Measure Information:
Title
Number of Participants Who Achieved Complete Healing or Coverage of the Study Wound
Description
How many wounds fully healed in 16 weeks. Healing defined as fully epithelialized skin with no drainage.
Time Frame
16 weeks
Secondary Outcome Measure Information:
Title
Total Adverse Events of Participants
Description
Total number of adverse events, including new foot ulcer formation, all-cause hospital readmission, and foot-related hospital readmission.
Time Frame
16 Weeks
Title
Number of Participants With Wound Dehiscence After Hospital Discharge
Description
Dehiscence is defined as any part of a surgically closed wound that failed to heal when sutures were removed.
Time Frame
16 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
89 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of diabetes mellitus Men/women ≥21 years old Foot or ankle wounds sized 5 cm2 -100 cm2 ABI≥0.5 or toe pressures >30 mmHg Exclusion Criteria: Active Charcot arthropathy Unable to use NPWT at home Untreated bone or soft tissue infection Unable to keep research appointments Active alcohol or substance abuse
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lawrence A Lavery, DPM
Organizational Affiliation
UT Southwestern Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
UT Southwestern Medical Center at Dallas
City
Dallas
State/Province
Texas
ZIP/Postal Code
75390
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
32139102
Citation
Lavery LA, Davis KE, La Fontaine J, Farrar JD, Bhavan K, Oz OK, Crisologo PA. Does negative pressure wound therapy with irrigation improve clinical outcomes? A randomized clinical trial in patients with diabetic foot infections. Am J Surg. 2020 Oct;220(4):1076-1082. doi: 10.1016/j.amjsurg.2020.02.044. Epub 2020 Feb 27.
Results Reference
derived

Learn more about this trial

Negative Pressure Wound Therapy as a Drug Delivery System

We'll reach out to this number within 24 hrs